According to a newly published market research report by 24LifeSciences, global Kaposi Sarcoma market was valued at USD 97.0 million in 2024 and is projected to reach USD 119.1 million by 2031, growing at a compound annual growth rate (CAGR) of 3.0% during the forecast period 2025–2031. Kaposi Sarcoma (KS), caused by Human Herpesvirus 8 (HHV-8), is an angioproliferative malignancy...